Associate professor of General Pathology at Università degli Studi di Milano, Milan, Italy
2005, PhD in Endocrinological and Metabolic Sciences
2002, Degree in Pharmaceutical Chemistry and Technology
2021 – National academic qualification as a full professor of general pathology
2020 – Associate professor of general pathology
2017 to 2020: 3-years temporary contract as an assistant professor: letter B.
2017 – National academic qualification as an associate professor
2013-2016: 3-years temporary contract as an assistant professor: letter A.
2005-2013: post-Doctoral fellowship
2003-2004 PhD fellowship, San Bartholomew Hospital, London, Queen Mary University of London (Prof. M. Korbonits and A. Grossman)
2002-2005: Ph.D. student (Università degli Studi di Milano)
- Endocrine Society, Eugenia Rosemberg Award in conjunction with ENDO 2016 in
- Young Investigator Award – XVII International Symposium on Drugs Affecting Lipid
Metabolism (DALM) – Diabetes, Obesity and The Metabolic Syndrome. Doha (Qatar)
Field of study
In recent years, my research activity has been centered on the role of proprotein convertase subtilisin kexin type 9 (PCSK9) in the context of molecular mechanisms leading to atheroma formation. To pursue this aim, epidemiological, in vitro and in vivo studies have been conducted. Last two years have been dedicated to epidemiological evaluation of lipoprotein(a) in the field of coronary revascularization and nonalcoholic fatty liver disease.
H-index: 35 (scopus) number of publications: 169